Category: Uncategorized

COUNTERFEIT MEDS are common when bought from online pharmacies, who use fake locations and affiliations. Over 4,000 were nabbed by the FDA and law enforcement recently. This is the most cynical of businesses, targeting the sick. http://lnkd.in/piRR3X View in LinkedIn

NEW R&D MODEL needed for antibiotic innovation is proposed: public-private partnerships. We all know that we have over-used antibiotics. And that resistant strains (Superbugs) are emerging. And that the pipeline is sparse because Big Pharma has left the sector. This call for a new initiative is in line with other similar open innovation public-private initiatives worldwide and let's hope it is adopted. http://lnkd.in/cRt2Hb View in LinkedIn

POC DIAGNOSTICS that can act in minutes not days (after pathogen cultures) for serious enteric pathogens offer a significant advantage where speed and accuracy of diagnosis is key. The culture days are facing extinction. Similarly, growing vaccines in chicken's eggs, which takes a long time, is also facing extinction by new recombinant methods, combined with in Silico antigen selection. http://lnkd.in/enkNY8 View in LinkedIn

GOOGLE BREAKS HIRING RULES by being contrarian, but the results are there. Take-home: (1) college had not prepared applicants for working on complex data-driven projects, and (2) most interviews failed to identify great employees. Great read! http://lnkd.in/zNTvVd View in LinkedIn

INTELLIGENT DRUGS, such as photo switchable drugs to limit side effects are emerging at the forefront of "making good drugs better" and increasing patient compliance and outcomes. http://lnkd.in/sR_3PP View in LinkedIn

MICROCHIP FOR ANTIBIOTIC-RESISTANT pathogens. This innovative technology takes the guesswork out of antibiotic prescribing, because it determines which antibiotics a pathogen in a biological sample (such as blood or tissue) is resistant to. Like the technology that tests drug sensitivity of tumor cells in vitro (Vivia Biotech), it makes the drug target, not the patient, the test tube. A lovely advance that should be widely used. http://lnkd.in/ebAzE9 View in LinkedIn

NEW CONDUCTIVE MATERIALS make for electronics as wearable devices, no longer silicon-trapped. Clothes with embedded devices, phones, heart monitors, GPS, the list of the possible is infinite. Boundaries until recently limited by silicon-based electronics are being shattered. Smart walls, responsive buildings, it is open season for anybody with an imagination and curiosity. Imagine the possibilities and start your new company around one of them! http://lnkd.in/WUyrQU View in LinkedIn

THE DEEP WEB is another world with anonymity and a criminal element: as if the existing web gave us limited information (not my experience), and how much information can we cope with (Big Data)? http://lnkd.in/m-W7RG View in LinkedIn

MYRIAD CASE BACKGROUNDER relating to the recent Supreme Court decision on gene patenting: a valuable read. http://www.metrocorpcounsel.com/articles/24396/landmark-case-comes-down View in LinkedIn

LESS DISEASE TARGETS? That is the assumption in traditional Pharma strategy thinking. But reflect on this: firstly, less than 2% of the druggable human genome has been spoken for. Secondly, severe tropical diseases kill tens of millions annually. The first will open due to genetics and already is (ie: genetically tailored cancer meds). The second is about economics. But as climate change drives more diseases like Dengue Fever into places like Texas, this too will change. Tropical diseases are migrating. Increasingly on our doorstep, they will attract Pharma attention. Not just Mr Gates. http://lnkd.in/4kEv6V View in LinkedIn